Renalytix Ai Stock Buy Hold or Sell Recommendation
| RNLX Stock | USD 0.15 0.01 6.25% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Renalytix AI is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Renalytix AI given historical horizon and risk tolerance towards Renalytix. When Macroaxis issues a 'buy' or 'sell' recommendation for Renalytix AI, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Renalytix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Renalytix and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Renalytix |
Execute Renalytix Buy or Sell Advice
The Renalytix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Renalytix AI. Macroaxis does not own or have any residual interests in Renalytix AI or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Renalytix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Renalytix Trading Alerts and Improvement Suggestions
| Renalytix AI generated a negative expected return over the last 90 days | |
| Renalytix AI has high historical volatility and very poor performance | |
| Renalytix AI has some characteristics of a very speculative penny stock | |
| Renalytix AI has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.29 M. Net Loss for the year was (33.46 M) with profit before overhead, payroll, taxes, and interest of 720 K. | |
| Renalytix AI currently holds about 32.36 M in cash with (30.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Renalytix plc Reports Financial Results for First Quarter of Fis - GuruFocus.com |
Renalytix Returns Distribution Density
The distribution of Renalytix's historical returns is an attempt to chart the uncertainty of Renalytix's future price movements. The chart of the probability distribution of Renalytix daily returns describes the distribution of returns around its average expected value. We use Renalytix AI price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Renalytix returns is essential to provide solid investment advice for Renalytix.
| Mean Return | -0.87 | Value At Risk | -9.52 | Potential Upside | 7.14 | Standard Deviation | 6.56 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Renalytix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Renalytix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Renalytix, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Renalytix AI back and forth among themselves.
| Shares | Lpl Financial Corp | 2024-06-30 | 18.4 K | Ewa, Llc | 2024-06-30 | 16.5 K | Jpmorgan Chase & Co | 2024-06-30 | 16.2 K | Baader Bank Inc | 2024-09-30 | 15 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 14.5 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 12.9 K | Virtu Financial Llc | 2024-06-30 | 12.5 K | Ironwood Investment Counsel, Llc | 2024-06-30 | 12 K | Cim, Llc | 2024-06-30 | 12 K | Pinnacle Associates Inc | 2024-09-30 | 846.5 K | Stifel Financial Corp | 2024-06-30 | 561 K |
Renalytix Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (849K) | 1M | (662K) | (370K) | (4K) | (4.2K) | |
| Change In Cash | 6.0M | 51.9M | (23.8M) | (16.7M) | (20.0M) | (19.0M) | |
| Depreciation | (485K) | 2.1M | 2.6M | 2.5M | 364K | 345.8K | |
| Capital Expenditures | 1.3M | 1.6M | 694K | 0.0 | 4K | 3.8K | |
| Net Income | (10.6M) | (35.8M) | (49.6M) | (46.2M) | (33.5M) | (35.1M) | |
| End Period Cash Flow | 13.3M | 65.2M | 41.3M | 24.7M | 4.7M | 4.4M | |
| Change To Netincome | 399K | 2.4M | (945K) | 5.3M | 4.7M | 5.7M | |
| Free Cash Flow | (11.4M) | (26.3M) | (46.4M) | (32.7M) | (30.1M) | (31.6M) | |
| Other Non Cash Items | 873K | (495K) | (5.8M) | (55K) | 3.6M | 4.5M |
Renalytix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Renalytix or Health Care Technology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Renalytix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Renalytix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.87 | |
β | Beta against Dow Jones | -0.08 | |
σ | Overall volatility | 6.48 | |
Ir | Information ratio | -0.15 |
Renalytix Volatility Alert
Renalytix AI is displaying above-average volatility over the selected time horizon. Renalytix AI is a potential penny stock. Although Renalytix may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Renalytix AI. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Renalytix instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Renalytix Fundamentals Vs Peers
Comparing Renalytix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Renalytix's direct or indirect competition across all of the common fundamentals between Renalytix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Renalytix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Renalytix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Renalytix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Renalytix to competition |
| Fundamentals | Renalytix | Peer Average |
| Return On Equity | -10.73 | -0.31 |
| Return On Asset | -0.94 | -0.14 |
| Operating Margin | (9.43) % | (5.51) % |
| Current Valuation | 40.06 M | 16.62 B |
| Shares Outstanding | 82.96 M | 571.82 M |
| Shares Owned By Insiders | 4.51 % | 10.09 % |
| Shares Owned By Institutions | 4.13 % | 39.21 % |
| Number Of Shares Shorted | 378.92 K | 4.71 M |
| Price To Book | 18.77 X | 9.51 X |
| Price To Sales | 9.85 X | 11.42 X |
| Revenue | 2.29 M | 9.43 B |
| Gross Profit | 720 K | 27.38 B |
| EBITDA | (28.52 M) | 3.9 B |
| Net Income | (33.46 M) | 570.98 M |
| Cash And Equivalents | 32.36 M | 2.7 B |
| Cash Per Share | 0.89 X | 5.01 X |
| Total Debt | 8.54 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 2.48 X | 2.16 X |
| Book Value Per Share | (0.05) X | 1.93 K |
| Cash Flow From Operations | (30.11 M) | 971.22 M |
| Short Ratio | 0.39 X | 4.00 X |
| Earnings Per Share | (0.62) X | 3.12 X |
| Target Price | 2.5 | |
| Beta | 2.1 | -0.15 |
| Market Capitalization | 22.55 M | 19.03 B |
| Total Asset | 7.97 M | 29.47 B |
| Retained Earnings | (211.78 M) | 9.33 B |
| Working Capital | 12.2 M | 1.48 B |
| Net Asset | 7.97 M |
Note: Acquisition by Icahn School Of Medicine At Mount Sinai of 13366750 shares of Renalytix at 0.116 subject to Rule 16b-3 [view details]
Renalytix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Renalytix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Renalytix Buy or Sell Advice
When is the right time to buy or sell Renalytix AI? Buying financial instruments such as Renalytix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Renalytix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Renalytix Stock Analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.